Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

12 Stocks Moving In Tuesday's Pre-Market Session

MRNS, ZBH, INFIQ, BIDU, RVNC, MESO


Gainers

Yingli Green Energy Holding Co Ltd (ADR) (NYSE: YGE) rose 15.29 percent to $4.90 in pre-market trading following earnings results. Yingli Green posted Q1 earnings of $0.60 per ADS on revenue of $364.6 million.

Achaogen Inc (NASDAQ: AKAO) shares rose 5.54 percent to $4 in pre-market trading. Wedbush upgraded Achaogen from Neutral to Outperform.

Eleven Biotherapeutics Inc (NASDAQ: EBIO) shares rose 4.60 percent to $2.50 in pre-market trading after surging 27.81 percent on Monday.

Twitter Inc (NYSE: TWTR) rose 2.20 percent to $14.87 in pre-market trading after gaining 3.78 percent on Monday.

Marinus Pharmaceuticals Inc (NASDAQ: MRNS) rose 2 percent to $1.65 in pre-market trading after dipping 69.66 percent on Monday. RBC Capital downgraded Marinus Pharmaceuticals from Outperform to Sector Perform.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares fell 65.99 percent to $1.50 in pre-market trading. Infinity announced plans to cut 21 percent of the workforce. The company also reported that DYNAMO Phase 2 monotherapy study evaluating the efficacy and safety of duvelisib met its primary endpoint.

Mesoblast limited (ADR) (NASDAQ: MESO) shares fell 36.35 percent to $4.50 as the company issued an update on global heart failure program. The company reported that it has regained rights to cardiovascular field for cell therapy platform.

Revance Therapeutics Inc (NASDAQ: RVNC) shares fell 23.60 percent to $14.02 in pre-market trading as the company reported that its REALISE 1 Phase 3 trial of DaxibotulinumtoxinA Topical Gel (RT001) to treat patients with moderate to severe lateral canthal lines (crow’s feet) had failed to meet co-primary and other endpoints.

ImmunoGen, Inc. (NASDAQ: IMGN) shares fell 13.13 percent to $4.30 in pre-market trading after the company announced a private offering of $100 million in convertible senior notes.

Western Gas Equity Partners LP (NYSE: WGP) shares fell 8.98 percent to $37.99 in pre-market trading. Western Gas Equity Partners priced 12.5 million common unit offering for gross proceeds of $481 million.

Baidu Inc (ADR) (NASDAQ: BIDU) shares fell 5.29 percent to $154.90 in pre-market trading as the company lowered its revenue guidance for the second quarter. The company projects Q2 revenue of $2.81 billion to $2.82 billion, versus its earlier forecast of $3.12 billion to $3.19 billion.

Zimmer Biomet Holdings Inc (NYSE: ZBH) fell 2.49 percent to $115.30 in pre-market trading. Zimmer Biomet priced its 11.1 million share offering for $115.85 per share.